GlassScriptPhysician profile
Christopher Lewis
NPI 1932533015
$10,819.85
in general payments reported to CMS, 2019-2025
7 companies · $2,553 in 2025
The $2,553 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $105 · 2023: $3,189 · 2024: $4,972 · 2025: $2,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,569 · Travel and Lodging: $4,835 · Education: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,569.39 |
| Travel and Lodging | $4,834.52 |
| Education | $310.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,134.81 | 2022-2025 | Watchman Access System, Emblem Mri S-Icd, Watchman Flx |
| Medtronic, INC. | $3,798.85 | 2023-2025 | Micra, Crome Dr Mri Surescan, Amplia Mri Quad Crt-D Surescan |
| Biosense Webster, INC. | $1,244.01 | 2024-2025 | Carto 3, Qdot Micro Catheter |
| Philips North America LLC | $506.95 | 2023-2025 | Igt Devices Systems Undivided |
| Chiesi USA, INC. | $69.30 | 2024-2025 | Kengreal, Cleviprex |
| Cardiva Medical, INC. | $49.47 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astrazeneca Pharmaceuticals LP | $16.46 | 2025 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.